All In Biotech

Drug Trial Radar · NCT05324293

To Evaluate the Safety, Tolerability and Efficacy in Male and Female with AGA Treated with HMI-115 Over a 24-week Treatment Period

An Open Label Study, to Evaluate Safety, Tolerability, and Efficacy in Male and Female with Androgenetic Alopecia Treated with HMI-115 Over a 24-Week Treatment Period

Last checked: Nov 19, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

16

Actual

Start

May 11, 2022

Primary completion

Sep 11, 2023

Study completion Sep 11, 2023

Sponsor

Sponsor type
Industry
First posted
Apr 12, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An Open Label Study, to Evaluate Safety, Tolerability, and Efficacy Study in Male and Female with Androgenetic Alopecia Treated with HMI-115 over a 24-Week Treatment Period.

Conditions

  • Androgenetic Alopecia

Interventions

  • HMI-115Drug

    Once Every 2 weeks, subcutaneously injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. TAHC(target area hair count) of non-vellusTime frame: From baseline to Week 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr Rodney Sinclair Pty Ltd, trading as Sinclair Dermatology

    Melbourne E., Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.